Literature DB >> 29949667

The association of length of hospital stay with readmission after elective pancreatic resection.

Aditya Mazmudar1, Joshua Castle1, Anthony D Yang1, David J Bentrem1.   

Abstract

OBJECTIVE: The aim of this study was to identify if prolonged length of hospital stay was protective for certain post-discharge complications requiring readmission after pancreatectomy.
METHODS: Patients undergoing elective pancreatectomy from 2012 to 2013 were identified in the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). Multivariate regression analyses were conducted to elucidate the association of length of hospital stay (LOS), in-hospital complications, and post-discharge complications with 30-day hospital readmission.
RESULTS: Mean LOS for the readmitted versus not readmitted cohort was 9.01 and 10.36, respectively (P < 0.001). Approximately half of hospital readmissions occur within 7 days of discharge from the hospital. The readmission rate (after hospital discharge) for patients with any in-hospital complication was 13.2%. On the other hand, the readmission rate for patients with any post-discharge complication was 70.8%. Readmission rates were above 85% for patients with the following post-discharge complications: organ/space surgical site infection (SSI), pneumonia, ventilator dependence greater than 48 h, progressive renal insufficiency, sepsis, and septic shock. In a multivariate logistic regression model, prolonged LOS reduced the odds of any post-discharge complication requiring readmission (OR = 0.68, P = 0.01). Specifically, prolonged LOS reduced the odds of a post-discharge organ/space SSI requiring readmission (OR = 0.72, P = 0.02).
CONCLUSION: Readmission after pancreatectomy primarily occurs due to a new post-discharge event. Furthermore, increased LOS is protective for readmission for post-pancreatectomy complications, particularly those due to post-discharge organ space SSIs. Our findings suggest that solely focusing on reducing LOS in pancreatectomy may lead to the unintended consequence of increasing readmission rates.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  NSQIP; length of stay; organ space surgical site infections; readmission

Mesh:

Year:  2018        PMID: 29949667     DOI: 10.1002/jso.25093

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Composite Length of Stay, An Outcome Measure of Postoperative and Readmission Length of Stays in Pancreatoduodenectomy.

Authors:  Gregory A Williams; Jingxia Liu; William C Chapman; William G Hawkins; Ryan C Fields; Dominic E Sanford; Majella B Doyle; Chet W Hammill; Adeel S Khan; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2019-12-16       Impact factor: 3.452

2.  Extending Enhanced Recovery after Surgery Protocols to the Post-Discharge Setting: A Phone Call Intervention to Support Patients after Expedited Discharge after Pancreaticoduodenectomy.

Authors:  Rony Takchi; Gregory A Williams; David Brauer; Tina Stoentcheva; Crystal Wolf; Brooke Van Anne; Cheryl Woolsey; William G Hawkins
Journal:  Am Surg       Date:  2020-01-01       Impact factor: 1.002

3.  Enhanced recovery pathway after open pancreaticoduodenectomy reduces postoperative length of hospital stay without reducing composite length of stay.

Authors:  Rony Takchi; Heidy Cos; Gregory A Williams; Cheryl Woolsey; Chet W Hammill; Ryan C Fields; Steven M Strasberg; William G Hawkins; Dominic E Sanford
Journal:  HPB (Oxford)       Date:  2021-06-16       Impact factor: 3.842

4.  Nomogram prediction of surgical site infection of HIV-infected patients following orthopedic surgery: a retrospective study.

Authors:  Rui Ma; Jie He; Biao Xu; Changsong Zhao; Yao Zhang; Xin Li; Sheng Sun; Qiang Zhang
Journal:  BMC Infect Dis       Date:  2020-11-26       Impact factor: 3.090

5.  Barriers to Post-Discharge Monitoring and Patient-Clinician Communication: A Qualitative Study.

Authors:  Brian C Brajcich; Meagan L Shallcross; Julie K Johnson; Rachel Hae-Soo Joung; Cassandra B Iroz; Jane L Holl; Karl Y Bilimoria; Ryan P Merkow
Journal:  J Surg Res       Date:  2021-07-23       Impact factor: 2.192

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.